Investors should review the full proxy statement to understand the qualifications of director nominees and the details of the stock award plan before voting. The shareholder proposal on board independence may be of particular interest to governance-focused investors.
Price Chart
Executive Summary
Bristol-Myers Squibb Co filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting. The filing outlines proposals for shareholder vote, including the election of 11 directors, an advisory vote on executive compensation, approval of a new stock award plan, ratification of the auditor, and a shareholder proposal to make the board chair independent.
Key Facts
- Filing is a definitive proxy statement (DEFA14A) for the 2026 Annual Meeting
- Proposals include election of 11 director nominees
- Advisory vote on executive compensation
- Vote to approve the 2026 Stock Award and Incentive Plan
- Ratification of the appointment of the independent auditor
- Shareholder proposal to adopt a board policy that the chairperson be independent
- Board recommends voting FOR all proposals except the shareholder proposal, which it recommends AGAINST
Financial Impact
No direct financial impact from this proxy filing. The proposals relate to corporate governance and executive compensation, not financial transactions.
Risk Factors
- Shareholder proposal may not pass if board recommendation is followed
- Potential for activist investor campaigns if governance concerns persist
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001140361-26-011110 |
| Document: 0001140361-26-011110-index-headers.html | 0001140361-26-011110 |
| Document: 0001140361-26-011110-index.html | 0001140361-26-011110 |
| Document: 0001140361-26-011110.txt | 0001140361-26-011110 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 6w ago | Institutional Cluster | $64.63 $63.73 | ▼ −1.39% | ▲ +0.58% | $61.46 (−4.90%) |
Aug 5, 2026 8w ago | ANALYST-UPGRADE | $63.63 $67.66 | ▲ +6.33% | ▲ +6.93% | $61.46 (−3.41%) |
Jul 30, 2026 9w ago | 8-K | $64.86 $66.95 | ▲ +3.22% | ▼ −0.74% | $61.46 (−5.24%) |
Mar 25, 2026 27w ago | DEFA14A | $59.39 $58.71 | ▼ −1.15% | ▼ −11.81% | $61.46 (+3.49%) |
Feb 26, 2026 31w ago | Court Ruling | $61.08 $59.39 | ▼ −2.77% | ▲ +3.63% | $61.46 (+0.63%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access